Cecil L Basham, Jr

Title: Cecil L Basham, Jr: Innovator in Bioagent Detection

Introduction

Cecil L Basham, Jr. is a notable inventor based in Del Mar, CA (US). He has made significant contributions to the field of bioagent detection through his innovative patent. His work focuses on methods and apparatus for genetic evaluation, which has important implications for various industries.

Latest Patents

Cecil L Basham, Jr. holds a patent for "Methods and apparatus for genetic evaluation." This patent describes a rapid and definitive approach to bioagent detection and identification that does not require nucleic acid sequencing. The technology allows for the analysis of various bioagents and samples, including air, fluid, and body samples. This analysis provides valuable information for industrial, medical, and environmental purposes. The process involves collecting nucleic acid samples of unknown or suspected bioagents, selecting optimal primer pairs, and amplifying the nucleic acid. Expected mass spectra signal models are generated, and the actual mass spectra of the amplicons are obtained. A joint maximum likelihood analysis is used to determine the expected mass spectra that most closely correlates with the actual mass spectra, leading to the identification of the most likely candidate bioagents.

Career Highlights

Cecil L Basham, Jr. has had a distinguished career, particularly in the field of bioagent detection. His innovative approaches have paved the way for advancements in genetic evaluation technologies. He is currently associated with Ibis Biosciences, Inc., where he continues to contribute to the development of cutting-edge solutions in this area.

Collaborations

Throughout his career, Cecil has collaborated with notable professionals in the field, including David J Ecker and Richard Holmes Griffey. These collaborations have further enhanced the impact of his work and have contributed to the advancement of bioagent detection technologies.

Conclusion

Cecil L Basham, Jr. is a pioneering inventor whose work in bioagent detection has significant implications for various sectors. His innovative patent and collaborations highlight his commitment to advancing technology in genetic evaluation. His contributions continue to shape the future of bioagent detection and identification.